¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑôÃß°ñ´Ù°øÁõ¿¬±¸È¸ Á¦11ȸ Á¤±âÇмú´ëȸ : 2024-03-23

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇÑôÃß°ñ´Ù°øÁõ¿¬±¸È¸ Á¦11ȸ Á¤±âÇмú´ëȸ : 2024-03-23
±³À°ÀÏÀÚ : 2024-03-23
±³À°Àå¼Ò : ¼­¿ï¼º¸ðº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç

±³À°ÁÖÁ¦ : ´ëÇÑôÃß°ñ´Ù°øÁõ¿¬±¸È¸ Á¦11ȸ Á¤±âÇмú´ëȸ

ÁÖÃÖ±â°ü : ´ëÇÑôÃ߽Űæ¿Ü°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑôÃß°ñ´Ù°øÁõ¿¬±¸È¸

´ã´çÀÚ : ¼ÛÁÖ¿µ
¿¬¶ôó : 02-585-5455

À̸ÞÀÏ : ksns1987@gmail.com

±³À°Á¾·ù : ½Å°æ¿Ü°ú, ÀÇ»çÇÐ, ÀÇÇб³À°

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 20,000¿ø  

ºñ°í ȸ¿ø 1¸¸¿ø, ºñȸ¿ø 2¸¸¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 09:10~09:30 The first choice of osteoporosis and osteopenia: Raloxifene and Vit. D Áø¿ëÁØ (ÀÎÁ¦´ë )

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 09:30~09:50 Lifelong sequential treatment of osteoporosis Á¤Á¦ÈÆ (¼øõÇâ´ë )

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 09:50~10:10 Romosozumab use of clinical practice in spine field ±Ç¿µ¹Î (µ¿¾Æ´ë )

Åä·Ð 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 10:10~10:20 Discussion ()

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 10:45~11:05 Treat-to-target strategy of osteoporosis management ÀÌÀ¯¹Ì (¿¬¼¼´ë ³»ºÐºñ³»°ú)

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 11:05~11:25 Guidelines for dental treatment during osteoporis treatment ±Ç¿ë´ë (°æÈñÄ¡´ë ±¸°­¾Ç¾È¸é¿Ü°ú )

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 11:25~11:45 BMP pathway and research for bone regeneration ÃÖÁ¦¿ë(°æºÏÀÇ´ë ¼¼Æ÷»ýÈ­Çб³½Ç )

Åä·Ð 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 11:45~11:55 Discussion ()

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 13:30~13:45 ÃÊ·Ï: Comparison of the difference between vertebral height restoration and global sagittal alignment after percutaneous vertebroplasty in thoracolumbar junction (unilateral vs. bilateral) ±è±¤·Ä (´ë±¸Ä«Å縯´ë)

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 13:45~14:00 ÃÊ·Ï: Radiologic fusion rates of OLIF surgery using E-coli derived BMP-2 ÀÌ»ó¿ì (°æºÏ´ë )

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 14:00~14:15 ÃÊ·Ï: Evaluation of the association between 2nd osteoporotic compression fractures and paraspinal muscle mass volume mesasured on MRI À±Á¦ÈÖ(¾ÆÁÖ´ë)

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 14:15~14:30 ÃÊ·Ï: Does ossification of the longitudinal ligament nifluence the fusion rate of posterior cervical fusion? ÀåÇöÁØ(¿¬¼¼´ë)

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 14:30~14:45 ÃÊ·Ï: Frailty and sarcopenia: Impact on outcomes following elective degenerative lumbar spine surgery À¯µ¿¿ì(¿µ³²´ë)

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 14:45~15:00 ÃÊ·Ï: Comparison of radiological and functional outcomes of conservative treatment with teriparatide and denosumab in thoracolumbar osteoporotic vertebral fracture Àü¼º¹Î(¿µ³²´ë)

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 15:20~15:40 Screw insertional torque measurement is spine surgery: correlation with BMD and Hounsfield unit ±èÁö¿ë(Ä«Å縯´ë ¼ººó¼¾Æ®º´¿ø)

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 15:40~16:00 The combined effects of RhBMP-2 and systemic RANKL inhibitor in patients with bone density loss undergoing PLIF À¯½ÂÁØ (À»Áö´ë)

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 16:00~16:20 Comparison of the efficacy of romosozumab and teriparatide for the management of osteoporotic vertebral compression fracture ¹ÚÁøÈÆ (¿ï»ê´ë ¾Æ»êº´¿ø )

Åä·Ð 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 16:20~16:30 Discussion ()

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 16:30~16:50 Effectiveness of bone cement augmented pedicle screw fixation in severe osteoporotic patients ³ë¼ºÇö(¾ÆÁÖ´ë)

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 16:50~17:10 Mini-open corpectomy and reconstruction cases for fragility fracture induced kyphosis À±¼±±Ù(¿ï»ê´ë ¾Æ»êº´¿ø )

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 17:10~17:30 Treatment of super-aged spondylitis patient with osteopenia ±èµ¿È¯(°æ»ó´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑôÃß°ñ´Ù°øÁõ¿¬±¸È¸ Á¦11ȸ Á¤±âÇмú´ëȸ : 2024-03-23""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑ°¡Á¤ÀÇÇÐȸ ÀüºÏÁöȸÃá°è¿¬¼ö°­Á : 2024-03-23
´ÙÀ½±Û 2024³â Á¦1Â÷ ´ëÇÑÇÙÀÇÇÐȸ Á¤µµ°ü¸® ½ÉÆ÷Áö¾ö : 2024-03-23
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
160 ¼­¿ï ¿øÀڷº´¿ø 2018³âµµ 2Â÷ ¹æ»ç¼±ºñ»óÁø·á ½Å±Ô±³À° (2ÀÏÂ÷) : 2018-08-31 0 569 2018-07-28
159 ¼­¿ï ´ëÇѼºÇü¿Ü°úÇÐȸ ±âÃÊÀÇÇבּ¸ È°¼ºÈ­ ¹× Ãʺ¸ÀÚ¸¦ À§ÇÑ ÄÁÆÛ·±½º : 2018-08-31 0 455 2018-07-28
158 ¼­¿ï °í·Á´ëÇб³±¸·Îº´¿ø 1) °áÇÕÁ¶Á÷ Áúȯ 2) ÇǺÎÁö¹æ Áúȯ : 2018-08-30 0 632 2018-07-28
157 ¼­¿ï Çѱ¹³ú½Å°æ°úÇÐȸ Knowing Brain, Healing Brain : 2018-08-30 0 456 2018-07-28
156 ºÎ»ê 2018 ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ(8¿ù 30ÀÏ) : 2018-08-30 0 582 2018-07-28
155 ¼­¿ï ´ëÇÑÀÇ»çÇùȸ [Á¦27±â ÀÇ·áÁ¤Ã¥ÃÖ°íÀ§°úÁ¤] 3Â÷ »ó´ë°¡Ä¡ °³Æí : 2018-08-30 0 949 2018-07-28
154 ¼­¿ï ¿øÀڷº´¿ø 2018³âµµ 2Â÷ ¹æ»ç¼±ºñ»óÁø·á ½Å±Ô±³À° (1ÀÏÂ÷) : 2018-08-30 0 909 2018-07-28
153 ºÎ»ê ´ëÇѾȰúÇÐȸ ÇмúÁý´ãȸ(³ì³»Àå, New trends of glaucoma treatment) : 2018-08-30 0 861 2018-07-28
152 °æ±â Çϳ²½Ã ÀÇ»çȸ ¿¬¼ö°­ÁÂ(Ç÷°ü¼ºÄ¡¸Å, °¨¿°³»°ú °¨¿°Áúȯ) : 2018-08-30 0 2,014 2018-07-28
151 ¼­¿ï ÀÎÁ¦´ëÇб³»ó°è¹éº´¿ø °¢¸· Áúȯ : 2018-08-29 0 689 2018-07-28
150 ´ë±¸ ´ë±¸°¡Å縯´ëÇб³º´¿ø Ȳ¹ÝºÎÁ¾ ¹× Ȳ¹Ýº¯¼º : 2018-08-28 0 646 2018-07-28
149 ´ë±¸ ´ëÇѾȰúÇÐȸ 2018³â ´ë±¸ °æºÏ ¾È°ú Áöȸ Á¤±â ¿¬¼ö±³À° : 2018-08-28 0 675 2018-07-28
148 ºÎ»ê ½Å°æ¿µ»óÀÇÇÐÀÇ ÇмúÁõ·Ê¹ßÇ¥ : 2018-08-28 0 286 2018-07-28
147 ºÎ»ê ´ëÇÑÀ忬±¸ÇÐȸ Á¤±âÁý´ãȸ : 2018-08-27 0 529 2018-07-28
146 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø ¼Ò¾ÆÀçÈ°ÀÇÇа­Á : 2018-08-26 0 558 2018-07-28
1361 | 1362 | 1363 | 1364 | 1365 | 1366 | 1367 | 1368 | 1369 | 1370
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷